CN103655742B - Preparation method of fukean tablet and application of fukean tablet in preparation of drugs for inhibition of cell proliferation of mouse embryonic carcinoma cell P19 - Google Patents
Preparation method of fukean tablet and application of fukean tablet in preparation of drugs for inhibition of cell proliferation of mouse embryonic carcinoma cell P19 Download PDFInfo
- Publication number
- CN103655742B CN103655742B CN201310653240.7A CN201310653240A CN103655742B CN 103655742 B CN103655742 B CN 103655742B CN 201310653240 A CN201310653240 A CN 201310653240A CN 103655742 B CN103655742 B CN 103655742B
- Authority
- CN
- China
- Prior art keywords
- preparation
- fukean tablet
- fukean
- tablet
- cell proliferation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 title claims abstract description 11
- 229940079593 drug Drugs 0.000 title claims abstract description 8
- 201000009030 Carcinoma Diseases 0.000 title abstract 2
- 230000035407 negative regulation of cell proliferation Effects 0.000 title abstract 2
- 238000000874 microwave-assisted extraction Methods 0.000 claims abstract description 11
- 239000011347 resin Substances 0.000 claims abstract description 7
- 229920005989 resin Polymers 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- 238000000605 extraction Methods 0.000 claims description 13
- 230000004663 cell proliferation Effects 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 208000001608 teratocarcinoma Diseases 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 7
- 229920002472 Starch Polymers 0.000 claims description 5
- 230000000274 adsorptive effect Effects 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 239000003480 eluent Substances 0.000 claims description 5
- 238000010828 elution Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 235000019698 starch Nutrition 0.000 claims description 5
- 239000008107 starch Substances 0.000 claims description 5
- 230000001629 suppression Effects 0.000 claims description 5
- 235000008216 herbs Nutrition 0.000 claims description 4
- 238000001179 sorption measurement Methods 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 241000209035 Ilex Species 0.000 abstract 1
- 235000003332 Ilex aquifolium Nutrition 0.000 abstract 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 abstract 1
- 235000002294 Ilex volkensiana Nutrition 0.000 abstract 1
- 244000267641 Jasminum elongatum Species 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 240000003109 Persicaria chinensis Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 244000294611 Punica granatum Species 0.000 abstract 1
- 235000014360 Punica granatum Nutrition 0.000 abstract 1
- 229930003935 flavonoid Natural products 0.000 abstract 1
- 150000002215 flavonoids Chemical class 0.000 abstract 1
- 235000017173 flavonoids Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 229960004756 ethanol Drugs 0.000 description 18
- 238000000034 method Methods 0.000 description 11
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 9
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 9
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 9
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 9
- 235000005493 rutin Nutrition 0.000 description 9
- 229960004555 rutoside Drugs 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 229930003944 flavone Natural products 0.000 description 7
- 235000011949 flavones Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 150000002213 flavones Chemical class 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000012531 culture fluid Substances 0.000 description 3
- 229960000935 dehydrated alcohol Drugs 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BNGXYYYYKUGPPF-UHFFFAOYSA-M (3-methylphenyl)methyl-triphenylphosphanium;chloride Chemical compound [Cl-].CC1=CC=CC(C[P+](C=2C=CC=CC=2)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 BNGXYYYYKUGPPF-UHFFFAOYSA-M 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000004900 laundering Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a preparation method and application of a fukean tablet. The preparation method of the fukean tablet is as follows: the fukean tablet is prepared from 1000 g of jasminum elongatum, 1000 g of Chinese knotweed, 670 g of ovate leaf holly bark, 330 g of plantain herb and 330 g of pomegranate peel as raw materials by use of microwave extraction and macroporous resin adsorption, and the total flavonoid content is greatly improved. The invention also provides application of the fukean tablet in preparation of drugs for inhibition of cell proliferation of mouse embryonic carcinoma cell P19.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of preparation method of fukean tablet and suppress the application in mouse teratocarcinoma cells P19 cell proliferation in preparation.
Background technology
Fukean tablet standard No. WS-10256(ZD-0256)-2002, be recorded in national standard for traditional Chinese medicines compilation internal medicine taste fascicle.Be made up as crude drug of Herba Oxalidis strictae 1000g, Herb Polygoni Chinensis 1000g, Cortex Ilicis Rotundae 670g, Herba Plantaginis 330g, Pericarpium Granati 330g, there is clearing away heat-damp and promoting diuresis, convergence, effect of pain relieving.The stomachache caused for acute gastroenteritis, dyspepsia, diarrhoea, vomiting.
In prior art, fukean tablet is not yet had to extract the report adopting microwave technology and macroporous resin adsorption extractive technique in preparation, and decocting in water alcohol extraction, technique is coarse, backward, and impurity is many, causes patient's consumption excessive, be inconvenient to take, had a strong impact on this product and applied clinically.
In prior art, fukean tablet is oral, one time 4,3 times on the one.Fukean tablet dosage is large.The heavy 0.3g of the every sheet of the fukean tablet adopting the inventive method to be prepared into, only needs 2 at every turn, within 1st, takes 3 times.Dose is greatly reduced under the condition with more active component.This conclusion can be proved by following test.
The comparison of general flavone content in fukean tablet prepared by test one, distinct methods
L, instrument and reagent fukean tablet of the present invention: by the preparation of embodiment 1 method, use 3330g crude drug, makes 500 through extracting, the heavy 0.3g of every sheet.Former fukean tablet, according to WS-10256(ZD-0256)-2002 standard method preparations, in contrast.Visible-ultraviolet light microwell plate detector (MD company of U.S. model: SPECTRAMAX190); METTLER AE240 electronic analytical balance; Control substance of Rutin (Nat'l Pharmaceutical & Biological Products Control Institute).
2, method
The preparation precision of reference substance solution takes at 120 DEG C of drying under reduced pressure appropriate to the control substance of Rutin of constant weight, adds 60% ethanol and makes the solution of every 1ml containing 0.1mg, to obtain final product.
The preparation precision of standard curve measures reference substance solution 1.0ml, 2.0ml, 3.0ml, 4.0ml, 5.0ml, put in 25ml measuring bottle respectively, respectively add 10% sodium nitrite solution 0.3ml, mixing, places 6 minutes, add 10% aluminum nitrate solution 0.3ml, mixing, places 6 minutes, add 4% sodium hydroxide solution 4ml, shake up, add 30% ethanol to scale, shake up, place 15 minutes; With corresponding solution for blank.According to spectrophotography (Chinese Pharmacopoeia version in 2000 annex V B) test, measure trap at 510nm wavelength place, take trap as vertical coordinate, concentration is abscissa, drawing standard curve.
Algoscopy gets this product under weight differential item, removing coating, porphyrize, (fukean tablet prepared of the inventive method gets 0.125g in sampling, former fukean tablet takes 0.2g), accurately weighed, put in round-bottomed flask, add methanol 25ml, shake up, reflux 1 hour, take out, be cooled to room temperature, filter, filter paper adds methanol 25ml again together with residue, reflux 1 hour, take out, cooling, filter, merging filtrate, residue methanol 15ml gradation is washed, washing liquid and filtrate merge, evaporate to dryness, residue adds 60% alcoholic solution makes dissolving, to be transferred in 50ml measuring bottle and to be diluted to scale, shake up.Precision measures 1ml, method under sighting target directrix curve preparation, from " putting respectively in 25ml measuring bottle ", measures trap in accordance with the law, reads the weight of rutin in need testing solution from standard curve, calculates, to obtain final product.
3, result
Result shows, in fukean tablet of the present invention, the content of total flavones counts 80-100mg/ sheet with rutin; And the content of total flavones counts 10.54mg/ sheet with rutin in former fukean tablet, every sheet rutin content is equivalent to the 8-10 of former tablet content doubly, and when dose reduces, general flavone content improves a lot.
Above-mentioned research shows, adopt fukean tablet prepared by preparation method of the present invention, active constituent content is far away higher than WS-10256(ZD-0256) fukean tablet prepared of method recorded of-2002 standards.
Summary of the invention
In order to solve above-mentioned technical problem, the invention provides a kind of preparation method of fukean tablet.
Another object of the present invention is to provide a kind of fukean tablet to suppress the application in mouse teratocarcinoma cells P19 cell proliferation in preparation.
The object of the invention is by following scheme realize:
A kind of preparation method of fukean tablet, by Herba Oxalidis strictae 1000g, Herb Polygoni Chinensis 1000g, Cortex Ilicis Rotundae 670g, Herba Plantaginis 330g, Pericarpium Granati 330g makes as crude drug, it is characterized in that, described preparation method is made up of the following step: get upper gomi herbs, pulverize, add 65% ethanol of 10L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 600-800W, extract 2 times, each 5-10 minute, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 65% ethanol elution, collect 5 times amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain microwave extraction thing, the mixing of microwave extraction thing is added starch, 70% ethanol granule, dry, tabletting, make 500, the heavy 0.3g of every sheet.
In the preparation method of above-mentioned fukean tablet, described microwave extracting power is 700W.
In the preparation method of above-mentioned fukean tablet, each extraction time of described microwave extracting is 8 minutes.
Above-mentioned fukean tablet suppresses the application in mouse teratocarcinoma cells P19 cell proliferation in preparation.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further described, so that those skilled in the art more understands the present invention, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
Embodiment 1
Get Herba Oxalidis strictae 1000g, Herb Polygoni Chinensis 1000g, Cortex Ilicis Rotundae 670g, Herba Plantaginis 330g, Pericarpium Granati 330g, add 65% ethanol of 10L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 700W, extract 2 times, each 8 minutes, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 65% ethanol elution, collect 5 times amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain microwave extraction thing, the mixing of microwave extraction thing is added starch, 70% ethanol granule, dry, tabletting, make 500, the heavy 0.3g of every sheet.
After testing, the content of finished product total flavones counts 98.92mg/ sheet with rutin
Embodiment 2
Get Herba Oxalidis strictae 1000g, Herb Polygoni Chinensis 1000g, Cortex Ilicis Rotundae 670g, Herba Plantaginis 330g, Pericarpium Granati 330g, by gomi herbs, pulverize, add 65% ethanol of 10L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 600W, extract 2 times, each 5 minutes, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 65% ethanol elution, collect 5 times amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain microwave extraction thing, the mixing of microwave extraction thing is added starch, 70% ethanol granule, dry, tabletting, make 500, the heavy 0.3g of every sheet.
After testing, in finished product, the content of total flavones counts 82.16mg/ sheet with rutin.
Embodiment 3
Get Herba Oxalidis strictae 1000g, Herb Polygoni Chinensis 1000g, Cortex Ilicis Rotundae 670g, Herba Plantaginis 330g, Pericarpium Granati 330g, by gomi herbs, pulverize, add 65% ethanol of 10L, drop in microwave extracting apparatus and carry out microwave extracting, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 800W, extract 2 times, each 10 minutes, combining extraction liquid, concentrated, be added on DiaionHP-10 macroporous adsorptive resins, 65% ethanol elution, collect 5 times amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain microwave extraction thing, the mixing of microwave extraction thing is added starch, 70% ethanol granule, dry, tabletting, make 500, the heavy 0.3g of every sheet.
After testing, in finished product, in finished product, the content of total flavones counts 90.44mg/ sheet with rutin.
Embodiment 4: fukean tablet suppresses the experimentation data of mouse teratocarcinoma cells P19 cell proliferation
1. experiment material
1.1 experiment cell strains
Mouse teratocarcinoma cells P19 cell, Shandong University's laboratory cell storehouse, DMEM+10%FBS cellar culture.
1.2 Experimental agents
Drugs: fukean tablet of the present invention: prepare by embodiment 1 method.
Medicinal liquid liquid storage: take 100mg fukean tablet, is dissolved in 5ml dehydrated alcohol, 0.2 μm of frit, 500 μ ldoff pipe subpackages ,-20 DEG C of storages, and simultaneously 0.2 μm of frit dehydrated alcohol is in order to the use of matched group.
1.3 experiment reagent
DMEM (GIBCO company Cat.No.12100-061Lot.No.758137); Hyclone (Tian Hang bio tech ltd, Zhejiang Lot.No.100419); NaHC0
3(Shanghai hundred million chemical reagent company limited Cat.No.11810-033Lot.No.1088387 of a specified duration); Trypsin(AMRESCO company); EDTA(AMRESCO company); Penicillin G Sodium Salt(AMRESCO company 1); Streptomycin Sulfate (AMRESCO); Dehydrated alcohol (Zibo Ya Dulan Trade Co., Ltd.); MTT (Biosharp lot number: 0793): PBS(laboratory autogamy);
1.4 experiment equipment
Lycra inverted microscope (German Leica model: DMIL); Visible-ultraviolet light microwell plate detector (MD company of U.S. model: SPECTRAMAX190); C0
2incubator (FORMA model: 3111); Super-clean bench (safe and sound Inc. of Su Jing group moulding number: SW-CJ-ZFD); Pure water instrument (Sprlng company of U.S. model: S/N020579); Accurate pipettor (French Gilson Inc model: P2); Electronic balance (German Sai Duolisi company limited model: BT323S); Full-automatic high-pressure autoclave (Japanese SANYO company model: MLS-3020); Table electrothermal air dry oven (the accurate experimental facilities company in Shanghai model: DHG9123A); Refrigerator (Siemens Company's model: KG18V21TI); Liquid nitrogen container (CBS model: 2001); Low speed centrifuge (Anting Scientific Instrument Factory, Shanghai's model: KA-1000); 0.2 μm of filter (MILLIPORE model: SLGP033RB); 1cm culture dish (NEST company), 96 well culture plates (NEST company); Cell counting count board; Centrifuge tube, pipet, Tips are some.
2. experimental technique
1) P19 cell DMEM+10%FBS is in 37 DEG C, 5%C0
2carry out cellar culture (10cm culture dish), when Growth of Cells is to logarithmic (log) phase, collecting cell, discards culture fluid, PBS fine laundering 3 times, add 3ml0.25% trypsin-0.04%EDTA, after 37 DEG C of digestion 2min, add 5ml complete medium neutralization reaction wherein, proceeded in centrifuge tube after piping and druming cell, the centrifugal 5min of 1000rpm, adjustment concentration of cell suspension 3 × 10
4individual/ml.
2) enter in 96 well culture plates by cell kind, every hole adds cell suspension 180 μ l, culture plate put into cell culture incubator (37 DEG C, 5%C0
2) cellar culture.
3) according to cell growth status, generally grow to 50%-70%, add fukean tablet solution, continue to cultivate 24h.
4) add 20 μ l MTT solution (5mg/ml, i.e. 0.5%MTT) after 24h, continue to cultivate 4h.
5) after 4h, buckle method removes supernatant, pats dry gently with absorbent paper, and every hole, as entered 200 μ l dimethyl sulfoxide, is put low-speed oscillation 10min on shaking table, crystal is fully dissolved.The light absorption value in each hole is measured at enzyme-linked immunosorbent assay instrument 490nm place.
6) background (do not add cell, only add culture fluid) is set, control wells (the medicine dissolution medium of cell, same concentrations, culture fluid, MTT, dimethyl sulfoxide) simultaneously, often organizes the multiple hole of setting 6.
7) result represents with the suppression ratio of medicine to cell: cell proliferation suppression ratio (%)=(control wells OD value-dosing holes OD value), control wells OD value × 100%.Experiment repetition 3 times.
3. statistical disposition
Adopt the correlation analysis in Microsoft Excel2007 software and Student t to check, data represent with mean ± S.D..
4. experimental result
Statistical result showed after mtt assay experiment, compare with matched group, when dosage reaches 5mg/ml, to P19 cell inhibitory effect variant (P<0.05), dosage this difference when 10mg/ml has significance (P<0.01), has pole significant difference (P<0.001) when dosage reaches 15-20mg/ml.
Table 1 fukean tablet is to P19 cell inhibitory effect influence research (X ± SD)
| Group | Drug level (mg/ml) | Suppression ratio (%) |
| Matched group | 0 | 0 |
| 1 | 5 | 7.96±7.54 |
| 2 | 10 | 13.02±10.83* |
| 3 | 15 | 26.09±13.96** |
| 4 | 20 | 37.49±16.91** |
Note: compare with matched group, * P<O.01; * P<0.001.
5. experiment conclusion
Fukean tablet can suppress P19 cell proliferation, and reduce the Growth of Cells number of P19 cell, this effect is dose dependent.
Claims (3)
1. the application of fukean tablet in preparation suppression mouse teratocarcinoma cells P19 cell proliferation, it is characterized in that, described fukean tablet is by Herba Oxalidis strictae 1000g, Herb Polygoni Chinensis 1000g, Cortex Ilicis Rotundae 670g, Herba Plantaginis 330g, Pericarpium Granati 330g makes as crude drug, the preparation method of described fukean tablet is made up of the following step: get upper gomi herbs, pulverize, add 65% ethanol of 10L, drop in microwave extracting apparatus and carry out microwave extracting, extraction power 600-800W, extract 2 times, each 5-10 minute, combining extraction liquid, concentrated, be added on Diaion HP-10 macroporous adsorptive resins, 65% ethanol elution, collect 5 times amount column volume eluents, decompression recycling ethanol, concentrated and dry, obtain microwave extraction thing, the mixing of microwave extraction thing is added starch, 70% ethanol granule, dry, tabletting, make 500, the heavy 0.3g of every sheet.
2. the fukean tablet according to claim l suppresses the application in mouse teratocarcinoma cells P19 cell proliferation in preparation, and it is characterized in that, described microwave extracting power is 700W.
3. the fukean tablet according to claim l suppresses the application in mouse teratocarcinoma cells P19 cell proliferation in preparation, and it is characterized in that, each extraction time of described microwave extracting is 8 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310653240.7A CN103655742B (en) | 2013-12-06 | 2013-12-06 | Preparation method of fukean tablet and application of fukean tablet in preparation of drugs for inhibition of cell proliferation of mouse embryonic carcinoma cell P19 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310653240.7A CN103655742B (en) | 2013-12-06 | 2013-12-06 | Preparation method of fukean tablet and application of fukean tablet in preparation of drugs for inhibition of cell proliferation of mouse embryonic carcinoma cell P19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103655742A CN103655742A (en) | 2014-03-26 |
| CN103655742B true CN103655742B (en) | 2015-07-15 |
Family
ID=50295301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310653240.7A Active CN103655742B (en) | 2013-12-06 | 2013-12-06 | Preparation method of fukean tablet and application of fukean tablet in preparation of drugs for inhibition of cell proliferation of mouse embryonic carcinoma cell P19 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103655742B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1887315A (en) * | 2006-05-24 | 2007-01-03 | 张嵩 | Fukean disperser tablet and its prepn |
| CN102127142A (en) * | 2010-12-28 | 2011-07-20 | 赵全成 | Ilicis routundae cortex derivants and application thereof in preparing medicament capable of resisting tumors |
| CN102824409A (en) * | 2012-09-24 | 2012-12-19 | 南京正亮医药科技有限公司 | Preparation method of liver protection tablets |
-
2013
- 2013-12-06 CN CN201310653240.7A patent/CN103655742B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1887315A (en) * | 2006-05-24 | 2007-01-03 | 张嵩 | Fukean disperser tablet and its prepn |
| CN102127142A (en) * | 2010-12-28 | 2011-07-20 | 赵全成 | Ilicis routundae cortex derivants and application thereof in preparing medicament capable of resisting tumors |
| CN102824409A (en) * | 2012-09-24 | 2012-12-19 | 南京正亮医药科技有限公司 | Preparation method of liver protection tablets |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103655742A (en) | 2014-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103655744B (en) | Preparation method for Fukean tablet and application of Fukean tablet in preparation of drug used for inhibiting proliferation of mouse lymphoma cell YAC-1 | |
| CN103655742B (en) | Preparation method of fukean tablet and application of fukean tablet in preparation of drugs for inhibition of cell proliferation of mouse embryonic carcinoma cell P19 | |
| CN103655743B (en) | A kind of preparation method of fukean tablet and the application in preparation suppression mouse lymphoma cell BL4 cell proliferation thereof | |
| CN105816536A (en) | Application of lawn pennywort herb liver-healing tablets in preparation of drug for inhibiting cell proliferation of cerebral tumor cells SF767 | |
| CN105412333A (en) | Application of hance brandisia herb tablets in preparation of medicine for inhibiting cell proliferation of glioma cells SHG-44 | |
| CN104306722A (en) | Preparation method of nine-herb false Chinese swertia herb tablets and application of nine-herb false Chinese swertia herb tablets in preparation of medicament for inhibiting cell proliferation of lymphoma cell EL4 | |
| CN104398810A (en) | Preparation method of nine flavor swertia bimaculata tablet and application of nine flavor swertia bimaculata tablet in preparation of drugs for inhibition of cell proliferation of neoplastic lymphoid cell P388D1 | |
| CN105343292A (en) | Application of hance brandisia herb tablets in preparation of drugs for inhibiting endometrial carcinoma cell HEC-1B proliferation | |
| CN105412170A (en) | Application of chimonanthus nitens leaf tablets in preparing medicine for inhibiting cell proliferation of breast tumor cell C127 | |
| CN103800770A (en) | Application of boenninghausenia cough tablet in preparing medicine for inhibiting cell proliferation of breast tumor cell C127 | |
| CN103735785A (en) | Application of lespedeza cuneata turbidness-eliminating tablet to preparation of medicament for suppressing cell proliferation of lymphoma cells YAC-1 | |
| CN105381062A (en) | Application of hance brandisia herb tablets in preparing drug for inhibiting cervical cancer cell Hela S3 proliferation | |
| CN105412330A (en) | Application of hance brandisia herb tablets in preparing medicine for inhibiting cell proliferation of breast medullary carcinoma cell Bcap-37 | |
| CN105362451A (en) | Application of hance brandisia herb tablets in preparation of melanoma cell M14 proliferation inhibiting drug | |
| CN104398814A (en) | Preparation method of nine flavor swertia bimaculata tablet and application of nine flavor swertia bimaculata tablet in preparation of drugs for inhibition of cell proliferation of leukemia cell L1210 | |
| CN104398816A (en) | Preparation method of nine flavor swertia bimaculata tablet and application of nine flavor swertia bimaculata tablet in preparation of drugs for inhibition of cell proliferation of teratoma cell P19 | |
| CN105434489A (en) | Application of chimonanthus nitens leaf tablets in preparing medicine for inhibiting cell proliferation of skin basal cell carcinoma cell A431 | |
| CN105412331A (en) | Application of hance brandisia herb tablets in preparation of medicine for inhibiting cell proliferation of prostate cancer cells PC-3 | |
| CN104398813A (en) | Preparation method of nine flavor swertia bimaculata tablet and application of nine flavor swertia bimaculata tablet in preparation of drugs for inhibition of cell proliferation of leukemia cell L6565 | |
| CN104306729A (en) | Preparation method of nine-herb false Chinese swertia herb tablets and application of nine-herb false Chinese swertia herb tablets in preparation of medicament for inhibiting cell proliferation of lung carcinoma cell LLC | |
| CN104398811A (en) | Preparation method of nine flavor swertia bimaculata tablet and application of nine flavor swertia bimaculata tablet in preparation of drugs for inhibition of cell proliferation of anus sarcoma cell S-180 | |
| CN104398812A (en) | Preparation method of nine flavor swertia bimaculata tablet and application of nine flavor swertia bimaculata tablet in preparation of drugs for inhibition of cell proliferation of breast tumor cell C127 | |
| CN105412175A (en) | Application of chimonanthus nitens leaf tablets in preparing medicine for inhibiting cell proliferation of uterus well-differentiated squamous cancer cell HCC | |
| CN104398815A (en) | Preparation method of nine flavor swertia bimaculata tablet and application of nine flavor swertia bimaculata tablet in preparation of drugs for inhibition of cell proliferation of melanoma cell B16 | |
| CN104398819A (en) | Preparation method of nine flavor swertia bimaculata tablet and application of nine flavor swertia bimaculata tablet in preparation of drugs for inhibition of cell proliferation of ascitic tumor cell SAC II B2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU MEI Free format text: FORMER OWNER: SHANDONG ZHONGDA PHARM CO., LTD. Effective date: 20150608 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Duode Inventor after: Liu Mei Inventor before: Wei Shutong Inventor before: Duan Xuewen |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WEI SHUTONG DUAN XUEWEN TO: WANG DUODE LIU MEI |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150608 Address after: 266000 Shandong province Qingdao City, Pingxiang Road No. 22 atrium Mountain District 6 Building 3 unit 401 Applicant after: Liu Mei Address before: 250062, No. ten, No. 16369, Lixia District, Ji'nan City, Shandong Province Applicant before: SHANDONG ZHONGDA PHARMACEUTICAL Co.,Ltd. |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230109 Address after: 2604-1, Floor 22, Building 2, No. 66, Zhongguancun East Road, Haidian District, Beijing 100190 Patentee after: Beijing Shunying Consulting Co.,Ltd. Address before: 266000 Room 401, unit 3, building 6, Zhongting Shanjing community, No. 22 Pingxiang Road, Shibei District, Qingdao, Shandong Province Patentee before: Liu Mei |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230625 Address after: 2603, 22nd Floor, Building 2, No. 66 Zhongguancun East Road, Haidian District, Beijing, 100190 Patentee after: Beijing Yuanshunfu Consulting Co.,Ltd. Address before: 2604-1, Floor 22, Building 2, No. 66, Zhongguancun East Road, Haidian District, Beijing 100190 Patentee before: Beijing Shunying Consulting Co.,Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20230817 Address after: Room 4014, No. 258 Fulin Road, Hengqin New District, Zhuhai City, Guangdong Province, 519031 Patentee after: Zhuhai Hengqin Maikairui Pharmaceutical Technology Co.,Ltd. Address before: 2603, 22nd Floor, Building 2, No. 66 Zhongguancun East Road, Haidian District, Beijing, 100190 Patentee before: Beijing Yuanshunfu Consulting Co.,Ltd. |